You are here

RN624 For Pain Of Post-Herpetic Neuralgia

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Anniston, Alabama, 36207 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Postherpetic Neuralgia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female of any race, at least 18 years of age.

- Patients must have pain present for more than 3 months after healing of the herpes
zoster skin rash.

- Has a pain score at screening that qualifies.

- Completes at least 3 average daily pain diaries during the 3 days prior to
randomization and has an average pain level that qualifies.

- Body Mass Index less than or equal to 39 kg/m2.

- If female, is post-menopausal, surgically sterile, or uses adequate contraception
consisting of 2 forms of birth control, one of which must be barrier method, is not
lactating, and is not breastfeeding.

- Male patients must agree that female spouses/partners will use contraception as
defined above or be of nonchildbearing potential (post-menopausal or surgically
sterile).

- Patients must be willing and able to comply with scheduled visits, treatment plan,
laboratory tests, and other study procedures.

- Patients must consent in writing to participate in the study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who cannot discontinue the use of other pain medications during the screening
period and during the study.

- Disqualifying scores on questionnaires.

- Other moderate to severe pain from other conditions.

- History of allergic or anaphylactic reaction to antibodies.

- Use of biologics, including any live vaccines within 3 months of the week prior to the
baseline visit.

- Unable to use acetaminophen.

- Disqualify laboratory values, Hepatitis B or C or HIV.

- Patients that have had a stroke or TIAs, dementia, epilepsy or seizures, or peripheral
neuropathy from other conditions.

- Significant cardiac disease within 3 months of the study such as angina, heart attack,
congestive heart failure, and other cardiac problems.

- Cancer other than basal cell or squamous cell carcinoma.

- Fails a urine test for illegal drugs including prescription drugs without a
prescription.

- Plans for surgery during the study.

- History of alcoholism or drug abuse in the past two years.

- Surgery for post-herpetic neuralgia.

- Any condition that the investigator feels would put the safety of the patient at risk.

NCT00568321
Pfizer
Completed
RN624 For Pain Of Post-Herpetic Neuralgia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Postherpetic Neuralgia
NCT00568321
All Genders
18+
Years
Multiple Sites
Neuralgia, Postherpetic Neuralgia
NCT00674687
All Genders
18+
Years
Liverpool,
Postherpetic Neuralgia
NCT00614705
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now